Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.
Adaptive immunity
Cathepsin
Inflammasome
Innate immunity
Mucopolysaccharidosis
NSG mouse
Thoracic aortic aneurysm
Journal
Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
13
10
2021
revised:
23
12
2021
accepted:
31
01
2022
pubmed:
16
2
2022
medline:
28
4
2022
entrez:
15
2
2022
Statut:
ppublish
Résumé
Adult immunocompetent male C57Bl/6 mucopolysaccharidosis, type I (MPSI) mice develop aortic insufficiency (AI), dilated ascending aortas and decreased cardiac function, findings not observed in immune incompetent adult male NSG MPSI mice. We sought to determine why. Cardiac ultrasound measurements of ascending aorta and left ventricular dimensions and Doppler interrogation for AI were performed in 6-month-old male B6 MPSI (N = 12), WT (N = 6), NSG MPSI (N = 8), NSG (N = 6) mice. Urinary glycosaminoglycans, RNA sequencing with quantitative PCR were performed and aortic pathology assessed by routine and immunohistochemical staining on subsets of murine aortas. Ascending aortic diameters were significantly greater, left ventricular function significantly decreased, and AI significantly more frequent in B6 MPSI mice compared to NSG MPSI mice (p < 0.0001, p = 0.008 and p = 0.02, respectively); NSG and B6 WT mice showed no changes. Urinary glycosaminoglycans were significantly greater in B6 and NSG MPSI mice and both were significantly elevated compared to WT controls (p = 0.003 and p < 0.0001, respectively). By RNA sequencing, all 11 components of the inflammasome pathway were upregulated in B6 MUT, but only Aim2 and Ctsb in NSG MUT mice and none in WT controls. Both B6 and NSG MUT mice demonstrated variably-severe intramural inflammation, vacuolated cells, elastin fragmentation and disarray, and intense glycosaminoglycans on histological staining. B6 MPSI mice demonstrated numerous medial MAC2+ macrophages and adventitial CD3+ T-cells while MAC2+ macrophages were sparse and CD3+ T-cells absent in NSG MPSI mice. Aortic dilation, AI and decreased cardiac function occur in immunocompetent B6 MPSI male mice but not in immune incompetent NSG MPSI mice, unrelated to GAG excretion, upregulation of Ctsb, or routine histologic appearance. Upregulation of all components of the inflammasome pathway in B6 MUT, but not NSG MUT mice, and abundant medial MAC2 and adventitial CD3 infiltrates in B6, but not NSG, MPSI aortas differentiated the two strains. These results suggest that the innate and adaptive immune systems play a role in these cardiac findings which may be relevant to human MPSI.
Sections du résumé
BACKGROUND
Adult immunocompetent male C57Bl/6 mucopolysaccharidosis, type I (MPSI) mice develop aortic insufficiency (AI), dilated ascending aortas and decreased cardiac function, findings not observed in immune incompetent adult male NSG MPSI mice. We sought to determine why.
METHODS
Cardiac ultrasound measurements of ascending aorta and left ventricular dimensions and Doppler interrogation for AI were performed in 6-month-old male B6 MPSI (N = 12), WT (N = 6), NSG MPSI (N = 8), NSG (N = 6) mice. Urinary glycosaminoglycans, RNA sequencing with quantitative PCR were performed and aortic pathology assessed by routine and immunohistochemical staining on subsets of murine aortas.
RESULTS
Ascending aortic diameters were significantly greater, left ventricular function significantly decreased, and AI significantly more frequent in B6 MPSI mice compared to NSG MPSI mice (p < 0.0001, p = 0.008 and p = 0.02, respectively); NSG and B6 WT mice showed no changes. Urinary glycosaminoglycans were significantly greater in B6 and NSG MPSI mice and both were significantly elevated compared to WT controls (p = 0.003 and p < 0.0001, respectively). By RNA sequencing, all 11 components of the inflammasome pathway were upregulated in B6 MUT, but only Aim2 and Ctsb in NSG MUT mice and none in WT controls. Both B6 and NSG MUT mice demonstrated variably-severe intramural inflammation, vacuolated cells, elastin fragmentation and disarray, and intense glycosaminoglycans on histological staining. B6 MPSI mice demonstrated numerous medial MAC2+ macrophages and adventitial CD3+ T-cells while MAC2+ macrophages were sparse and CD3+ T-cells absent in NSG MPSI mice.
CONCLUSIONS
Aortic dilation, AI and decreased cardiac function occur in immunocompetent B6 MPSI male mice but not in immune incompetent NSG MPSI mice, unrelated to GAG excretion, upregulation of Ctsb, or routine histologic appearance. Upregulation of all components of the inflammasome pathway in B6 MUT, but not NSG MUT mice, and abundant medial MAC2 and adventitial CD3 infiltrates in B6, but not NSG, MPSI aortas differentiated the two strains. These results suggest that the innate and adaptive immune systems play a role in these cardiac findings which may be relevant to human MPSI.
Identifiants
pubmed: 35165009
pii: S1096-7192(22)00132-9
doi: 10.1016/j.ymgme.2022.01.104
pmc: PMC9109621
mid: NIHMS1782455
pii:
doi:
Substances chimiques
Glycosaminoglycans
0
Inflammasomes
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-205Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
Am J Hum Genet. 2016 Sep 1;99(3):636-646
pubmed: 27588450
Inflamm Res. 2019 Apr;68(4):337-345
pubmed: 30758522
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):127-36
pubmed: 25378412
J Inherit Metab Dis. 2017 Mar;40(2):271-280
pubmed: 28054207
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
J Clin Pathol. 2008 Apr;61(4):519-23
pubmed: 17938162
Clin Chim Acta. 2020 Dec;511:14-23
pubmed: 32946794
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1902-7
pubmed: 12576554
Cold Spring Harb Perspect Biol. 2020 May 1;12(5):
pubmed: 31570336
Int J Mol Sci. 2020 Oct 16;21(20):
pubmed: 33081376
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20357-20359
pubmed: 32769206
J Leukoc Biol. 2020 Jul;108(1):323-338
pubmed: 32083338
Heart Vessels. 2019 Feb;34(2):290-295
pubmed: 30136169
J Thorac Cardiovasc Surg. 2019 Jan;157(1):37-42
pubmed: 30557953
Curr Opin Immunol. 2021 Feb;68:116-124
pubmed: 33181351
Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H169-H182
pubmed: 30412443
Gen Thorac Cardiovasc Surg. 2019 Jan;67(1):1-11
pubmed: 29204794
Mol Genet Metab. 2005 Sep-Oct;86(1-2):233-43
pubmed: 15979918
Am J Pathol. 2000 Mar;156(3):925-38
pubmed: 10702409
Mol Med. 2020 Sep 15;26(1):87
pubmed: 32933486
Biofilm. 2021 Jan 13;3:100043
pubmed: 33665610
Cell. 2010 Mar 19;140(6):821-32
pubmed: 20303873
Eur J Pediatr. 1995 Feb;154(2):98-101
pubmed: 7720756
FASEB J. 2019 Dec;33(12):13075-13084
pubmed: 31702392
Mol Genet Metab. 2008 Jul;94(3):298-304
pubmed: 18479957
Trends Immunol. 2019 Nov;40(11):1035-1052
pubmed: 31662274
Pediatr Res. 2006 Jan;59(1):27-32
pubmed: 16326988
J Vasc Surg. 2014 Mar;59(3):794-803
pubmed: 23790454
Cardiovasc Pathol. 2017 Mar - Apr;27:45-50
pubmed: 28104572
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Brain Res Bull. 2007 Nov 1;74(6):429-38
pubmed: 17920451
J Vasc Res. 2013;50(1):1-10
pubmed: 23018968
Front Immunol. 2013 Dec 18;4:470
pubmed: 24391644
Genet Med. 2018 Nov;20(11):1423-1429
pubmed: 29517765
Metab Brain Dis. 2020 Oct;35(7):1231-1236
pubmed: 32623553
Clin Genet. 1998 May;53(5):349-61
pubmed: 9660052
Circ Res. 2020 Apr 24;126(9):1260-1280
pubmed: 32324502
Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):819-821
pubmed: 34173004
In Vivo. 2014 Mar-Apr;28(2):189-96
pubmed: 24632972
Mol Med. 2014 Jun 19;20:230-7
pubmed: 24618883
Mol Ther Methods Clin Dev. 2015 Feb 11;2:14068
pubmed: 26052536
Annu Rev Physiol. 2011;73:29-46
pubmed: 20809794
J Cell Physiol. 2021 Jun;236(6):4455-4469
pubmed: 33319921
Herz. 2019 Apr;44(2):138-146
pubmed: 30747234
J Neurochem. 2019 Mar;148(5):639-651
pubmed: 30451296
Brief Bioinform. 2018 Nov 27;19(6):1247-1255
pubmed: 28605403
Toxicol Pathol. 2017 Jan;45(1):134-145
pubmed: 27815489
J Immunol. 1995 Jan 1;154(1):180-91
pubmed: 7995938
Am J Cardiol. 1976 Oct;38(4):487-501
pubmed: 823811
Ann Rheum Dis. 2017 Jul;76(7):1191-1198
pubmed: 27965258
J Heart Valve Dis. 2009 Sep;18(5):524-9
pubmed: 20099693
EMBO Mol Med. 2020 Mar 6;12(3):e11185
pubmed: 32057196
Int J Mol Sci. 2016 Nov 29;17(12):
pubmed: 27916847
Front Immunol. 2021 Feb 03;11:609161
pubmed: 33613530
Immunol Lett. 2021 Jun;234:16-32
pubmed: 33848562
Immunity. 2017 Oct 17;47(4):621-634
pubmed: 29045897
Hum Mol Genet. 1997 Apr;6(4):503-11
pubmed: 9097952
J Inherit Metab Dis. 2017 May;40(3):311-312
pubmed: 28160112
Curr Drug Targets. 2017;18(9):1019-1029
pubmed: 27538510
Immunol Rev. 2018 Jan;281(1):115-123
pubmed: 29247997
J Inherit Metab Dis. 2017 Mar;40(2):281-289
pubmed: 27743312
Biomed Pharmacother. 2020 Jan;121:109595
pubmed: 31710896
Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):694-706
pubmed: 28153878
Circ J. 2021 Nov 25;85(12):2129-2136
pubmed: 33883388